14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Feb 29, 2024 Sell 995 Smith Thomas B Common Stock
Feb 26, 2024 Sell 9 336 Dreyer Scott Common Stock
Feb 26, 2024 Sell 664 Dreyer Scott Common Stock
Feb 12, 2024 Buy 30 856 Tupper Colleen Common Stock
Feb 12, 2024 Sell 16 868 Tupper Colleen Common Stock
Feb 12, 2024 Sell 9 453 Tupper Colleen Common Stock
Feb 12, 2024 Buy 40 600 Tupper Colleen Common Stock
Feb 12, 2024 Buy 32 286 Dreyer Scott Common Stock
Feb 12, 2024 Sell 19 545 Dreyer Scott Common Stock
Feb 12, 2024 Sell 10 145 Dreyer Scott Common Stock
Feb 12, 2024 Buy 35 000 Dreyer Scott Common Stock
Feb 12, 2024 Buy 4 623 Smith Thomas B Common Stock
Feb 12, 2024 Sell 1 899 Smith Thomas B Common Stock
Feb 12, 2024 Sell 1 300 Smith Thomas B Common Stock
Feb 12, 2024 Buy 30 800 Smith Thomas B Common Stock
Feb 12, 2024 Buy 33 247 Kuhlmann Shirley R. Common Stock
Feb 12, 2024 Sell 21 146 Kuhlmann Shirley R. Common Stock
Feb 12, 2024 Sell 10 610 Kuhlmann Shirley R. Common Stock
Feb 12, 2024 Buy 43 400 Kuhlmann Shirley R. Common Stock
Feb 12, 2024 Buy 179 734 Ciaffoni Joseph Common Stock
Feb 12, 2024 Sell 47 445 Ciaffoni Joseph Common Stock
Feb 12, 2024 Sell 81 422 Ciaffoni Joseph Common Stock
Feb 12, 2024 Buy 119 000 Ciaffoni Joseph Common Stock
Jan 16, 2024 Sell 23 560 Dreyer Scott Common Stock
Dec 21, 2023 Buy 4 357 Ciaffoni Joseph Common Stock
Dec 21, 2023 Sell 4 357 Ciaffoni Joseph Common Stock
Dec 21, 2023 Sell 4 357 Ciaffoni Joseph Stock Option (Right to Purchase)
Dec 20, 2023 Buy 26 454 Ciaffoni Joseph Common Stock
Dec 20, 2023 Sell 26 454 Ciaffoni Joseph Common Stock
Dec 20, 2023 Sell 26 454 Ciaffoni Joseph Stock Option (Right to Purchase)
Dec 19, 2023 Buy 14 516 Ciaffoni Joseph Common Stock
Dec 19, 2023 Sell 14 516 Ciaffoni Joseph Common Stock
Dec 19, 2023 Sell 14 516 Ciaffoni Joseph Stock Option (Right to Purchase)
Dec 18, 2023 Buy 27 798 Ciaffoni Joseph Common Stock
Dec 18, 2023 Sell 27 798 Ciaffoni Joseph Common Stock
Dec 18, 2023 Sell 27 798 Ciaffoni Joseph Stock Option (Right to Purchase)
Nov 27, 2023 Buy 25 600 Kuhlmann Shirley R. Common Stock
Nov 27, 2023 Sell 25 600 Kuhlmann Shirley R. Common Stock
Nov 27, 2023 Sell 25 600 Kuhlmann Shirley R. Stock Option (Right to Purchase)
Jun 26, 2023 Sell 16 621 Kuhlmann Shirley R. Common Stock
Jun 26, 2023 Sell 1 363 Kuhlmann Shirley R. Common Stock
Jun 02, 2023 Sell 30 272 Ciaffoni Joseph Common Stock
Jun 02, 2023 Sell 1 000 Ciaffoni Joseph Common Stock
Jun 01, 2023 Sell 31 272 Ciaffoni Joseph Common Stock
May 31, 2023 Sell 31 272 Ciaffoni Joseph Common Stock
May 30, 2023 Sell 31 271 Ciaffoni Joseph Common Stock
May 18, 2023 Buy 9 792 Balice-gordon Rita J. Common Stock
May 18, 2023 Buy 9 792 Mcfarlane Neil F. Common Stock
May 18, 2023 Buy 9 792 Heffernan Michael Thomas Common Stock
May 18, 2023 Buy 9 792 Freund John Gordon Common Stock
May 18, 2023 Buy 9 792 Fallon John A. Common Stock
May 18, 2023 Buy 9 792 Melincoff Gwen A Common Stock
May 18, 2023 Buy 9 792 Santini Gino Common Stock
May 18, 2023 Buy 9 792 Bohlin Garen G Common Stock
Mar 15, 2023 Sell 31 640 Tupper Colleen Common Stock
Mar 01, 2023 Sell 13 324 Dreyer Scott Common Stock
Feb 13, 2023 Sell 21 811 Kuhlmann Shirley R. Common Stock
Feb 13, 2023 Buy 11 250 Ciaffoni Joseph Common Stock
Feb 13, 2023 Sell 11 250 Ciaffoni Joseph Common Stock
Feb 13, 2023 Sell 11 250 Ciaffoni Joseph Stock Option (Right to Purchase)
Feb 10, 2023 Buy 31 185 Smith Thomas B Common Stock
Feb 10, 2023 Buy 25 739 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Sell 16 291 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Sell 7 755 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Buy 48 125 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Buy 12 565 Tupper Colleen Common Stock
Feb 10, 2023 Sell 6 967 Tupper Colleen Common Stock
Feb 10, 2023 Sell 3 887 Tupper Colleen Common Stock
Feb 10, 2023 Buy 45 045 Tupper Colleen Common Stock
Feb 10, 2023 Buy 137 694 Ciaffoni Joseph Common Stock
Feb 10, 2023 Sell 44 121 Ciaffoni Joseph Common Stock
Feb 10, 2023 Sell 59 736 Ciaffoni Joseph Common Stock
Feb 10, 2023 Buy 117 500 Ciaffoni Joseph Common Stock
Feb 10, 2023 Buy 22 459 Dreyer Scott Common Stock
Feb 10, 2023 Sell 14 529 Dreyer Scott Common Stock
Feb 10, 2023 Sell 6 797 Dreyer Scott Common Stock
Feb 10, 2023 Buy 44 275 Dreyer Scott Common Stock
Jan 09, 2023 Sell 10 424 Dreyer Scott Common Stock
Jan 09, 2023 Sell 7 341 Dreyer Scott Common Stock
Jan 09, 2023 Sell 69 Dreyer Scott Common Stock
Dec 27, 2022 Buy 15 995 Heffernan Michael Thomas Common Stock
Dec 27, 2022 Buy 3 820 Heffernan Michael Thomas Common Stock
Dec 27, 2022 Sell 3 820 Heffernan Michael Thomas Common Stock
Dec 27, 2022 Sell 15 995 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 27, 2022 Sell 3 820 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 27, 2022 Sell 1 804 Ciaffoni Joseph Common Stock
Dec 27, 2022 Sell 400 Ciaffoni Joseph Common Stock
Dec 23, 2022 Buy 4 989 Heffernan Michael Thomas Common Stock
Dec 23, 2022 Sell 4 989 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 23, 2022 Sell 147 Ciaffoni Joseph Common Stock
Dec 22, 2022 Buy 237 Heffernan Michael Thomas Common Stock
Dec 22, 2022 Sell 237 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 22, 2022 Sell 110 Ciaffoni Joseph Common Stock
Dec 21, 2022 Buy 46 600 Heffernan Michael Thomas Common Stock
Dec 21, 2022 Sell 46 600 Heffernan Michael Thomas Common Stock
Dec 21, 2022 Sell 46 600 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 20, 2022 Sell 33 758 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 20, 2022 Buy 33 758 Heffernan Michael Thomas Common Stock
Dec 19, 2022 Sell 3 606 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 19, 2022 Buy 3 606 Heffernan Michael Thomas Common Stock
INSIDER POWER
13.738
Last 100 transactions
Buy: 1 331 449 | Sell: 1 023 987 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 13.738.

In total, the insiders bought 1 331 449 and sold 1 023 987 COLL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT